Clearmind Medicine gets safety board approval to continue alcohol disorder trial
Clearmind Medicine Inc. (NASDAQ: CMND) received a positive recommendation from its independent Data and Safety Monitoring Board to continue its ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
